Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 16 March 2010
[DOI: 10.1126/scisignal.2000771]

Supplementary Materials for:

Cholinergic Augmentation of Insulin Release Requires Ankyrin-B

Jane A. Healy, Kent R. Nilsson, Hans E. Hohmeier, Jelena Berglund, Jonathan Davis, Janis Hoffman, Martin Kohler, Luo-Sheng Li, Per-Olof Berggren, Christopher B. Newgard, Vann Bennett*

*To whom correspondence should be addressed. E-mail: benne012{at}

This PDF file includes:

  • Fig. S1. Characteristics of ankyrin-B expression in B6 mouse islets and ankyrin-B and IP3R expression in ankB mouse islets.
  • Fig. S2. Effect of ankyrin-B knockdown on the abundance of IP3R and muscarinic receptor (M3R).
  • Fig. S3. Metabolic characteristics and islet parameters for ankyrin-B mice.
  • Table S1. Clinical characteristics of GENNID probands and R/W heterozygotes.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 19.7 MB

Citation: J. A. Healy, K. R. Nilsson, H. E. Hohmeier, J. Berglund, J. Davis, J. Hoffman, M. Kohler, L.-S. Li, P.-O. Berggren, C. B. Newgard, V. Bennett, Cholinergic augmentation of insulin release requires ankyrin-B. Sci. Signal. 3, ra19 (2010).

© 2010 American Association for the Advancement of Science

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882